Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for MIRM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 438.29M
March 31, 2026 386.26M
December 31, 2025 383.33M
September 30, 2025 375.55M
June 30, 2025 304.55M
March 31, 2025 277.67M
December 31, 2024 280.32M
September 30, 2024 284.44M
June 30, 2024 278.37M
March 31, 2024 302.84M
December 31, 2023 286.33M
September 30, 2023 306.03M
June 30, 2023 329.95M
March 31, 2023 132.07M
December 31, 2022 151.72M
Date Value
September 30, 2022 185.35M
June 30, 2022 124.95M
March 31, 2022 139.91M
December 31, 2021 156.54M
September 30, 2021 190.03M
June 30, 2021 223.85M
March 31, 2021 213.11M
December 31, 2020 231.82M
September 30, 2020 133.75M
June 30, 2020 149.34M
March 31, 2020 159.53M
December 31, 2019 116.66M
September 30, 2019 126.26M
June 30, 2019 84.19M
March 31, 2019 49.49M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Incyte Corp. 4.536B
Insmed, Inc. 1.160B
Praxis Precision Medicines, Inc. 758.55M
ACADIA Pharmaceuticals, Inc. 956.47M
Alnylam Pharmaceuticals, Inc. 3.308B